Ian,
It appears that VLGC may be looking for a merger/buyout soon. What do you think?
Don
SOUTH SAN FRANCISCO, Calif., Feb 14 (Reuters) - ViroLogic Inc. reported on Wednesday a fourth-quarter loss that missed estimates, and the company, a developer of products to improve treatment of viral diseases including AIDS, warned of a wider-than-expected loss for 2001.
For fourth quarter 2000, Virologic said it lost $6.8 million, or 34 cents a share, on revenue of $2.8 million, compared with a loss of $6 million, or 63 cents, on revenue of $500,000 in the same 1999 quarter.
Wall Street analysts on average expected a per-share loss of 33 cents a share, according to First Call/Thomson Financial. |
